Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04659811 |
|---|---|
| Brief Title: | Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meningioma |
| First Submitted : | November 30, 2020 |
| First Submitted that Met QC Criteria : | December 2, 2020 |
| First Posted : | December 9, 2020 |
| Last Update Submitted that Met QC Criteria : | October 28, 2022 |
| Last Update Posted : | November 1, 2022 |